Notes to the Financial Statements
For the financial year ended 31 March 2015
ANNUAL REPORT FY2015
69
1.
GENERAL INFORMATION
Religare Health Trust (the “Trust”) is a business trust registered with the Monetary Authority of Singapore and domiciled in
Singapore. The Trust was constituted by the Trust Deed and is regulated by the Business Trusts Act, Chapter 31A of Singapore.
Under the trust deed, Religare Health Trust Trustee Manager Pte. Ltd. (the “Trustee-Manager”) has declared that it will hold all
the assets (including businesses) acquired on trust for the unitholders of the Trust. The registered office of the Trustee-Manager
is located at 9 Battery Road, #15-01 Straits Trading Building, Singapore 049910. The principal place of business of the Trustee-
Manager is located at 80 Raffles Place, #11-20 UOB Plaza 2, Singapore 048624.
The principal activity of the Trust is investment holding of hospital and health care related assets located in Asia, Australasia and
emerging markets in the rest of the world. The principal activities of the subsidiaries of the Trust are set out in Note 17.
The Trust was admitted to the Official List of the Main Board of Singapore Exchange Securities Trading Limited on 19 October 2012.
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1
Basis of preparation
These financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued
by International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost
convention, except as disclosed in the accounting policies below.
All financial information is presented in Singapore dollars and has been rounded to the nearest thousand, unless otherwise stated.
2.2
Changes in accounting policies
The accounting policies adopted are consistent with those of the previous financial year except in the current financial year,
the Group has adopted all the new and revised standards which are effective for annual financial periods beginning on or after
1 April 2014. The adoption of these standards did not have any effect on the financial performance or position of the Group and
the Company.
Standards, Amendments and Interpretations issued but not yet effective
The Group has not adopted the following standards that have been issued but not yet effective:
Description
Effective for annual
periods beginning
on or after
IAS 19
Defined Benefit Plans: Employee Contributions – Amendments to IAS 19
1 July 2014
Annual Improvements to IFRs 2010
–
2012 Cycle
1 July 2014
Annual Improvements to IFRs 2011
–
2013 Cycle
1 July 2014
IFRS 11 A
ccounting for Acquisitions of Interests in Joint Operations – Amendments to IFRS 11
1 January 2016
IAS 16 and IAS 38
Clarification of Acceptable Methods of Depreciation and Amortisation – Amendments
to IAS 16 and IAS 38
1 January 2016
IAS 16 and IAS 41
Agriculture: Bearer Plants – Amendments to IAS 16 and IAS 41
1 January 2016
IAS 27
Equity Method in Separate Financial Statements – Amendments to IAS 27
1 January 2016
IFRS 10 and IAS 28
Sale or Contribution of Assets between an Investor and its Associate or Joint Venture –
Amendments to IFRS 10 and IAS 28
1 January 2016
IFRS 10, IFRS 12 and IAS 28
Investment Entities: Applying the Consolidation Exception or Contribution of
Assets between an Investor and its Associate or Joint Venture – Amendments to IFRS 10, IFRS 12 and IAS 28
1 January 2016
IAS 1
Disclosure Initiative – Amendments to IAS 1
1 January 2016
Annual Improvements to IFRs 2012 – 2014 Cycle
1 January 2016
IFRS 15
Revenue from Contracts with Customers
1 January 2017
IFRS 9 Financial Instruments (issued in 2014)
1 January 2018
